Chronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches Emilie CayssialsFrancois Guilhot Leading Article 13 May 2017 Pages: 143 - 149
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering Xiaojie YuMichael J. E. MarshallMax Crispin Review Article 02 May 2017 Pages: 151 - 166
PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook Belinda Di BartoloDaniel J. SchererStephen J. Nicholls Review Article 19 April 2017 Pages: 167 - 174
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community Richard MarkusJennifer LiuPrimal Kaur Review Article Open access 24 April 2017 Pages: 175 - 187
Biosimilars in the United States: Emerging Issues in Litigation Alice Yuen-Ting WongMartha M. RumoreAlbert Wai-Kit Chan Review Article 19 April 2017 Pages: 189 - 205
Interleukin-1 Blockade: An Update on Emerging Indications Anoop MistrySinisa SavicJeroen C. H. van der Hilst Review Article 11 May 2017 Pages: 207 - 221
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents Walter ReinischJørgen JahnsenDae Hyun Yoo Original Research Article Open access 11 May 2017 Pages: 223 - 237
Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain Iara DaSilvaAna HuertaSpanish Group for the Study of Glomerular Diseases (GLOSEN) Original Research Article 22 May 2017 Pages: 239 - 249
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma Caroline GoussenSteve SimoneauBenoît Flan Original Research Article Open access 15 May 2017 Pages: 251 - 261
Golimumab: A Review in Inflammatory Arthritis James E. Frampton Adis Drug Evaluation 22 May 2017 Pages: 263 - 274
CT-P10 (Truxima™): A Rituximab Biosimilar Emma D. Deeks Adis Biosimilar Brief 11 May 2017 Pages: 275 - 278